Literature DB >> 24402392

Is obesity a marker of robustness in vulnerable hospitalized aged populations? Prospective, multicenter cohort study of 1 306 acutely ill patients.

P-O Lang1, R Mahmoudi, J-L Novella, E Tardieu, L-A Bertholon, P Nazeyrollas, F Blanchard, D Jolly, M Dramé.   

Abstract

BACKGROUND: The "obesity paradox" is poorly understood in vulnerable older hospitalized populations.
OBJECTIVES: To prospectively analyze the impact of body mass index (BMI) and comorbidities on early (6-week), one- and two-year mortality.
DESIGN: Prospective multicenter study with a two-year follow-up of old patients participating in the SAFES cohort study. SETTINGS: Nine university hospitals in France. PARTICIPANTS: Patients aged 75 or older hospitalized in medical divisions through the emergency department. MEASUREMENT: Inpatients' characteristics were obtained through a comprehensive geriatric assessment of inpatients, conducted in the first week of hospitalization. All-cause mortalities at 6-week, one- and two-year were determined using bivariable and multivariable Cox proportional hazard model.
RESULTS: The SAFES cohort included 1,306 patients, aged 85±6 years, with a majority of women (65%). One- and two-year mortality were inversely associated with BMI ≥30 kg/m2 while early mortality was not, and positively associated with age, burden of comorbidities, walking disorders, level of dependency and presence of a dementia syndrome. Survival rates between patients in low (< 18.0 kg/m2) and intermediate (18-24.9 and 25-29.9 kg/m2) BMI categories were not significant.
CONCLUSION: While our findings seem to confirm the reality of the "obesity paradox" in vulnerable older hospitalized population, the exact understanding of underlying mechanisms and even the truthfulness of this paradoxical relationship are still fraught with considerable methodological, epidemiological and metabolic challenges.

Entities:  

Mesh:

Year:  2014        PMID: 24402392     DOI: 10.1007/s12603-013-0352-9

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  48 in total

1.  The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program.

Authors:  S Kalmijn; J D Curb; B L Rodriguez; K Yano; R D Abbott
Journal:  Int J Obes Relat Metab Disord       Date:  1999-04

2.  The association between the body mass index and 4-year all-cause mortality in older hospitalized patients.

Authors:  Dina Zekry; François R Herrmann; Ulrich M Vischer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-10-10       Impact factor: 6.053

3.  Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

Authors:  M Z Molnar; E Streja; C P Kovesdy; S Bunnapradist; M S Sampaio; J Jing; M Krishnan; A R Nissenson; G M Danovitch; K Kalantar-Zadeh
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

4.  A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.

Authors:  Takayoshi Suganami; Junko Nishida; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

5.  Early markers of prolonged hospital stays in older people: a prospective, multicenter study of 908 inpatients in French acute hospitals.

Authors:  Pierre-Olivier Lang; Damien Heitz; Guy Hédelin; Moustapha Dramé; Nicolas Jovenin; Joël Ankri; Dominique Somme; Jean-Luc Novella; Jean Bernard Gauvain; Pascal Couturier; Thierry Voisin; Benoît De Wazière; Régis Gonthier; Claude Jeandel; Damien Jolly; Olivier Saint-Jean; François Blanchard
Journal:  J Am Geriatr Soc       Date:  2006-07       Impact factor: 5.562

6.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

7.  The "metabolically-obese," normal-weight individual.

Authors:  N B Ruderman; S H Schneider; P Berchtold
Journal:  Am J Clin Nutr       Date:  1981-08       Impact factor: 7.045

8.  A measure of primary sociobiological functions.

Authors:  S Katz; C A Akpom
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

9.  The obesity paradox in chronic disease: facts and numbers.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-03-14       Impact factor: 12.910

Review 10.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

View more
  4 in total

1.  Overall and abdominal adiposity in midlife and subsequent cognitive function.

Authors:  E Kesse-Guyot; V A Andreeva; M Touvier; C Jeandel; M Ferry; S Hercberg; P Galan
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

2.  Cross-sectional associations between different measures of obesity and muscle strength in men and women in a British cohort study.

Authors:  V L Keevil; R Luben; N Dalzell; S Hayat; A A Sayer; N J Wareham; K-T Khaw
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

3.  Determination of Cutoff Values for DEXA-Based Body Composition Measurements for Determining Metabolic and Cardiovascular Health.

Authors:  Pierre-Olivier Lang; Christophe Trivalle; Thomas Vogel; Jacques Proust; Jean-Pierre Papazyan; Moustapha Dramé
Journal:  Biores Open Access       Date:  2015-01-01

Review 4.  Interventions to restore appropriate immune function in the elderly.

Authors:  Richard Aspinall; Pierre Olivier Lang
Journal:  Immun Ageing       Date:  2018-01-25       Impact factor: 6.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.